TrialSurgery today2019

A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy.

Kazuhiko Yoshimatsu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.